NOT-TR-21-004: Notice of Early Termination of PAR-18-910, Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)

Notice of Early Termination of PAR-18-910, Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)

Notice Number:

NOT-TR-21-004

Key Dates

Release Date:

October 6, 2020

Related Announcements

PAR-18-910 - Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

The National Center for Advancing Translational Sciences (NCATS) announces the early termination of PAR-18-910, Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required). NCATS will not accept applications in response to PAR-18-910 for the August 26, 2021 submission date.

This Notice does not affect applications in response to these funding opportunities that have already been reviewed. Applications reviewed for FY 2021 funding will be selected for funding using the usual NCATS procedures. For grants that already have been awarded, NCATS plans to continue support for non-competing awards in future years.

Inquiries

Please direct all inquiries to:

Bobbie Ann Mount, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-435-0824
Email:newtherapeuticuses@mail.nih.gov